Clinical Trials of Stem Cell Treatment for Spinal Cord Injury
There are more than one million patients worldwide suffering paralysis caused by spinal cord injury (SCI). SCI causes severe socioeconomic problems not only to the patients and their caregivers but also to society; therefore, the development of innovative treatments is crucial. Many pharmacological...
Main Authors: | Kazuyoshi Yamazaki, Masahito Kawabori, Toshitaka Seki, Kiyohiro Houkin |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-06-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/11/3994 |
Similar Items
-
Neurogenesis as a Tool for Spinal Cord Injury
by: Katerina Havelikova, et al.
Published: (2022-03-01) -
Clinical Trials of Stem Cell Therapy for Cerebral Ischemic Stroke
by: Masahito Kawabori, et al.
Published: (2020-10-01) -
The Multiple Roles of FGF Signaling in the Developing Spinal Cord
by: Ruth Diez del Corral, et al.
Published: (2017-06-01) -
Advances in Neural Stem Cell Therapy for Spinal Cord Injury: Safety, Efficacy, and Future Perspectives
by: Sungjoon Lee, et al.
Published: (2022-12-01) -
Corrigendum: Activation of A2A receptor by PDRN reduces neuronal damage and stimulates WNT/β-catenin driven neurogenesis in spinal cord injury
by: Natasha Irrera, et al.
Published: (2022-11-01)